Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
16 Jun, 2026, 02.24 PM IST
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
15 Jun, 2026, 11.08 AM IST
India risks becoming "unhealthier before it becomes richer," CEA V Anantha Nageswaran warnsIndia faces a health challenge before achieving wealth. Chief Economic Advisor V Anantha Nageswaran points to rising obesity and sedentary ...
14 Jun, 2026, 05.29 PM IST
Hair loss due to soft drinks: Hair transplant surgeon explains whether drinking soda with meals can make you go baldCold drink causing hair loss: Daily cold drink habits might affect hair health. Doctors note a link between sugary beverages and conditions...
12 Jun, 2026, 11.28 AM IST
The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to knowFish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...
01 Jun, 2026, 08.50 PM IST
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
29 May, 2026, 05.30 AM IST
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
1 fruit, 5 benefits: Top nutritionist shares why having raw amla on an empty stomach can improve overall healthConsuming raw amla on an empty stomach offers significant health benefits, according to nutritionist Lovneet Batra. This practice enhances ...
21 May, 2026, 12.04 PM IST
Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billionBiocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as success...
11 May, 2026, 09.00 AM IST
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
08 May, 2026, 10.19 PM IST
Artificial sweeteners may alter gut health and metabolism across generations, new study suggestsNew research suggests artificial sweeteners like sucralose and stevia could alter gut bacteria and metabolism. These changes may persist ac...
07 May, 2026, 11.49 AM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Diabetes type 2, weight loss treatment can be done under single procedure? Research reveals big health updateDiabetes type 2 treatment: Trial participants either underwent a procedure used to improve blood sugar control in type 2 diabetes called du...
25 Apr, 2026, 06.20 PM IST
Tired of acne? Dermatologist lists six food items that can lead to an acne breakoutDermatologist Dr. Aanchal Panth advises that diet significantly impacts acne. She recommends avoiding milk, sugar, fast food, white bread, ...
01 Apr, 2026, 04.24 PM IST
Biocon gets US FDA nod to launch insulin glargineThe product branded as Semglee has an identical amino acid sequence to Sanofi’s Lantus® and is approved for the same indications. This is t...
12 Jun, 2020, 09.54 AM IST
National Pharmaceutical Pricing Authority exempts price controls for 3 insulins of WockhardtNPPA has exempted drug maker Wockhardt’s three insulin products from price controls for five years, starting January 8, 2015.
24 Nov, 2015, 12.59 AM IST
NPPA exempts price controls for three insulins of WockhardtIndia’s drug pricing watchdog, the National Pharmaceutical Pricing Authority (NPPA), has exempt drug maker Wockhardt’s three insulin produc...
23 Nov, 2015, 04.38 PM IST